The tariff classification of Minoxidil (CAS No. 38304-91-5) in bulk powder form, from Italy
Issued November 8, 2017 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2933.59.5900
Headings: 2933
Product description
Minoxidil is indicated for use as an antihypertensive vasodilator drug and as a hair-growth stimulant for the treatment of hair loss.
CBP rationale
The applicable subheading for the Minoxidil in bulk powder form will be 2933.59.5900, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: Other: Drugs: Other.
Full text
N291112 November 8, 2017 CLA-2-29:OT:RR:NC:N1:138 CATEGORY: Classification TARIFF NO.: 2933.59.5900 Ms. Sheila Heerdt Ren Pharm International Ltd. 350 Jericho Turnpike, Suite 204 Jericho, NY 11753 RE: The tariff classification of Minoxidil (CAS No. 38304-91-5) in bulk powder form, from Italy Dear Ms. Heerdt: In your letter dated October 12, 2017, you requested a tariff classification ruling. Minoxidil is indicated for use as an antihypertensive vasodilator drug and as a hair-growth stimulant for the treatment of hair loss. The applicable subheading for the Minoxidil in bulk powder form will be 2933.59.5900, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: Other: Drugs: Other.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
The tariff classification of Acyclovir (CAS No. 59277-89-3) in bulk form, from Spain
The tariff classification of Imatinib (CAS No. 152459-95-5) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk powder form, from Italy
The tariff classification of Tipiracil Hydrochloride (CAS No. 183204-72-0) in bulk powder form, from Italy
The tariff classification of Tofacitinib Citrate (CAS 540737-29-9), imported in bulk powder form, from Spain
The tariff classification of Dipyridamole (CAS-58-32-2) in bulk form, from India
The tariff classification of Sapropterin Dihydrochloride (CAS-69056-38-8) in bulk form, from Italy
The tariff classification of Entecavir (CAS-142217-69-4), in bulk form, from India
The tariff classification of Allopurinol (CAS-315-30-0) in bulk form, from Spain
The tariff classification of Fluorouracil (CAS-51-21-8), imported in bulk form, from China
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →